Basilea Pharmaceutica AG (LON: 0QNA)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 22, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	427	394	490	393	475	392
Market Cap Growth	-6.57%	-19.52%	24.78%	-17.40%	21.18%	13.16%
Enterprise Value	471	471	571	447	548	407
Last Close Price	35.39	33.42	41.15	33.38	44.00	36.56
PE Ratio	-	40.46	44.94	-	-	-
PS Ratio	3.16	2.68	3.69	3.27	4.50	3.74
PB Ratio	28.08	-42.28	-26.35	-8.27	-5.63	-5.41
P/TBV Ratio	28.90	-	-	-	-	-
P/FCF Ratio	50.50	31.48	139.32	-	-	-
P/OCF Ratio	45.76	29.69	77.36	-	-	-
EV/Sales Ratio	3.54	3.20	4.31	3.72	5.19	3.89
EV/EBITDA Ratio	-	21.78	29.31	154.82	-	-
EV/EBIT Ratio	-	23.05	30.58	183.33	-	-
EV/FCF Ratio	57.29	37.59	162.43	-	-	-
Debt / Equity Ratio	6.70	-12.86	-9.03	-3.74	-2.37	-2.14
Debt / EBITDA Ratio	-	5.05	7.76	41.61	-	-
Debt / FCF Ratio	12.05	9.57	47.76	-	-	-
Asset Turnover	0.71	0.80	0.63	0.62	0.57	0.53
Inventory Turnover	4.38	4.13	4.19	5.33	6.11	7.37
Quick Ratio	2.96	2.48	1.96	1.22	3.87	2.08
Current Ratio	4.10	3.20	2.34	1.38	4.46	2.45
Return on Equity (ROE)	-4.10%	-	-	-	-	-
Return on Assets (ROA)	-2.05%	6.95%	5.56%	0.79%	-5.93%	-3.89%
Return on Capital (ROIC)	-2.73%	9.61%	7.96%	1.25%	-10.88%	-8.30%
Earnings Yield	-0.13%	2.47%	2.23%	-1.41%	-2.56%	-4.46%
FCF Yield	1.93%	3.18%	0.72%	-6.73%	-9.75%	-12.75%
Buyback Yield / Dilution	6.73%	-1.67%	-2.24%	-13.62%	4.41%	0.76%
Total Shareholder Return	6.73%	-1.67%	-2.24%	-13.62%	4.41%	0.76%

Source: S&P Capital IQ. Standard template. Financial Sources.